Tese_Tânia Vieira.pdf - Ubi Thesis
Tese_Tânia Vieira.pdf - Ubi Thesis
Tese_Tânia Vieira.pdf - Ubi Thesis
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Chapter I - Introduction<br />
biomedical and pharmaceutical applications (Carmen Rodríguez-Argüelles et al. 2011).<br />
Furthermore, it also presents very important biological properties among which antimicrobial,<br />
anti-inflammatory, and antioxidant (Carmen Rodríguez-Argüelles et al. 2011).<br />
Figure 4 – Representation of the chitosan chemical structure(Kumirska et al. 2011).<br />
In this work, the chitosan aqueous solution was added to dextran sulfate polyanion<br />
aqueous solution. The formation of polycation–polyanion (polyelectrolyte) complex was mainly<br />
driven by an electrostatic mechanism where charge neutralization and possible local bridging<br />
(such as hydrogen bounding, Coulomb forces, van der Waals forces, and transfer forces) occurs<br />
(Yu et al. 2005; Meng et al. 2010). The advantages of chitosan/dextran nanoparticles are<br />
enhanced stability and increased mechanical strength compared with chitosan/tripolyphosphaste<br />
microparticles, whose lower stability and mechanical strength limit their application for drug<br />
delivery (Chen et al. 2007). It has also been reported that DNA and insulin structures are<br />
protected when dextran is used in the formulation of polyethylenimine/dextran nanoparticles<br />
(Chen et al. 2007). Dextran was also described as being capable of reducing the cationic chargerelated<br />
cytotoxicity of PEI nanoparticles in vitro (Chen et al. 2007). Therefore, it is possible that<br />
the combination of chitosan and dextran as matrix materials, in an optimal charge ratio, may act<br />
synergistically to incorporate and protect proteins and drugs, in order to reduce the toxicity of<br />
chitosan caused by its cationic charge (Kean et al. 2010).<br />
18